United Therapeutics Corp. (UTHR) Posts Mixed Q4 Results
Tweet Send to a FriendGet Alerts UTHR Hot Sheet
Price: $64.99 --0%
EPS Growth %: +58.2%
Financial Fact:
Basic (in shares): -105.8M
Today's EPS Names:
IHS, MEI, PIR, More
EPS Growth %: +58.2%
Financial Fact:
Basic (in shares): -105.8M
Today's EPS Names:
IHS, MEI, PIR, More
Trade UTHR Now!
United Therapeutics Corp. (NASDAQ: UTHR) reported Q4 EPS of $1.27, $0.65 better than the analyst estimate of $0.62. Revenue for the quarter came in at $166.5 million versus the consensus estimate of $174.87 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- Fedex Corp. (FDX) Tops Q4 EPS by 17c, Sales Light
- Clarcor, Inc. (CLC) Misses Q2 EPS by 1c; Lowers FY13 EPS Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
